Henry Schein, Inc. (NASDAQ:HSIC – Free Report) – Analysts at Leerink Partnrs cut their FY2025 EPS estimates for Henry Schein in a note issued to investors on Tuesday, November 5th. Leerink Partnrs analyst M. Cherny now anticipates that the company will earn $5.20 per share for the year, down from their prior estimate of $5.31. The consensus estimate for Henry Schein’s current full-year earnings is $4.76 per share. Leerink Partnrs also issued estimates for Henry Schein’s FY2026 earnings at $5.67 EPS and FY2027 earnings at $6.22 EPS.
Other analysts have also issued reports about the stock. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday. Barrington Research restated an “outperform” rating and issued a $82.00 price objective on shares of Henry Schein in a report on Wednesday. Evercore ISI raised their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Robert W. Baird lowered their price objective on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a report on Wednesday, August 7th. Finally, Baird R W upgraded shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. One analyst has rated the stock with a sell rating, six have given a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $77.50.
Henry Schein Stock Performance
Henry Schein stock opened at $68.00 on Friday. The company has a current ratio of 1.42, a quick ratio of 0.90 and a debt-to-equity ratio of 0.46. The firm has a 50-day moving average of $70.51 and a 200-day moving average of $69.73. The firm has a market cap of $8.48 billion, a P/E ratio of 27.98, a P/E/G ratio of 2.00 and a beta of 0.87. Henry Schein has a 1-year low of $62.12 and a 1-year high of $82.63.
Henry Schein (NASDAQ:HSIC – Get Free Report) last posted its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. The company had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein’s revenue for the quarter was up .4% on a year-over-year basis. During the same period in the prior year, the business posted $1.32 earnings per share.
Institutional Investors Weigh In On Henry Schein
Several institutional investors and hedge funds have recently made changes to their positions in HSIC. Cromwell Holdings LLC increased its position in shares of Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after acquiring an additional 170 shares in the last quarter. Summit Securities Group LLC bought a new stake in shares of Henry Schein during the second quarter valued at approximately $31,000. Beach Investment Counsel Inc. PA bought a new stake in shares of Henry Schein during the second quarter valued at approximately $37,000. Blue Trust Inc. increased its position in shares of Henry Schein by 104.2% during the second quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after acquiring an additional 475 shares in the last quarter. Finally, Farther Finance Advisors LLC increased its position in shares of Henry Schein by 58.9% during the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after acquiring an additional 346 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.
Insider Buying and Selling at Henry Schein
In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the transaction, the senior vice president now owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.14% of the company’s stock.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Read More
- Five stocks we like better than Henry Schein
- Investing in the High PE Growth Stocks
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- What is a Special Dividend?
- MarketBeat Week in Review – 11/4 – 11/8
- What are earnings reports?
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.